Personalized medicine for schizophrenia.
作者信息
Buckley Peter F, Miller Brian J
机构信息
Medical College of Georgia, Augusta University, 1120 15th Street, AA-1002, Augusta, GA 30912 USA.
出版信息
NPJ Schizophr. 2017 Jan 5;3:2. doi: 10.1038/s41537-016-0001-5. eCollection 2017.
Abstract
摘要
相似文献
1
Personalized medicine for schizophrenia.精神分裂症的个性化医疗。
NPJ Schizophr. 2017 Jan 5;3:2. doi: 10.1038/s41537-016-0001-5. eCollection 2017.
2
Genotype-based prevention of psychosis onset and schizophrenia: a personalized approach in a target population.基于基因型的精神病发作和精神分裂症预防：目标人群中的个性化方法。
Per Med. 2014 Mar;11(2):167-172. doi: 10.2217/pme.13.103. Epub 2013 Nov 11.
3
Personalized treatment of schizophrenia in everyday clinical practice: reality or fiction?日常临床实践中精神分裂症的个性化治疗：现实还是幻想？
Psychiatr Danub. 2015 Sep;27(3):314-8.
4
Taking Personalized Medicine Seriously: Biomarker Approaches in Phase IIb/III Studies in Major Depression and Schizophrenia.认真对待个性化医疗：重度抑郁症和精神分裂症IIb/III期研究中的生物标志物方法
Innov Clin Neurosci. 2015 Mar-Apr;12(3-4):26S-40S.
5
Impact of personalized in-home nursing care plans on dependence in ADLs/IADLs and on family burden among adults diagnosed with schizophrenia: a randomized controlled study.个性化居家护理计划对诊断为精神分裂症的成年人日常生活活动/工具性日常生活活动依赖和家庭负担的影响：一项随机对照研究。
Perspect Psychiatr Care. 2013 Jul;49(3):171-8. doi: 10.1111/j.1744-6163.2012.00347.x. Epub 2012 Jul 13.
6
Characterization CYP1A2, CYP2C9, CYP2C19 and CYP2D6 Polymorphisms Using HRMA in Psychiatry Patients with Schizophrenia and Bipolar Disease for Personalized Medicine.使用高分辨率熔解曲线分析技术对精神分裂症和双相情感障碍精神病患者的CYP1A2、CYP2C9、CYP2C19和CYP2D6基因多态性进行表征以实现个性化医疗。
Comb Chem High Throughput Screen. 2018;21(5):374-380. doi: 10.2174/1386207321666180619164726.
7
A computational algorithm for personalized medicine in schizophrenia.用于精神分裂症个体化医学的计算算法。
Schizophr Res. 2018 Feb;192:131-136. doi: 10.1016/j.schres.2017.05.001. Epub 2017 May 8.
8
Guest editorial: Special issue on machine learning in schizophrenia.特邀社论：精神分裂症机器学习特刊
Schizophr Res. 2019 Dec;214:1-2. doi: 10.1016/j.schres.2019.10.044. Epub 2019 Nov 9.
9
Role of intellectual property in investment-backed personalized medicine.知识产权在投资支持的个性化医疗中的作用。
Per Med. 2010 Jan;7(1):95-102. doi: 10.2217/pme.09.58.
10
Personalized medicine is more than genomic medicine: confusion over terminology impedes progress towards personalized healthcare.个性化医疗不仅仅是基因组医学：术语混淆阻碍了个性化医疗保健的发展进程。
Per Med. 2012 Jan;9(1):85-91. doi: 10.2217/pme.11.86.
引用本文的文献
1
The Inflammatory Nexus: Unraveling Shared Pathways and Promising Treatments in Alzheimer's Disease and Schizophrenia.炎症关联：揭示阿尔茨海默病和精神分裂症的共同途径及有前景的治疗方法
Int J Mol Sci. 2025 Jun 27;26(13):6237. doi: 10.3390/ijms26136237.
2
A dimensional approach to affective disorder: The relations between Scl-90 subdimensions and QEEG parameters.情感障碍的维度研究方法：症状自评量表90项症状清单各子维度与脑电地形图参数之间的关系。
Front Psychiatry. 2022 Aug 15;13:651008. doi: 10.3389/fpsyt.2022.651008. eCollection 2022.
3
Exonic deletions in IMMP2L in schizophrenia with enhanced glycation stress subtype.精神分裂症伴糖基化应激增强亚型中 IMMP2L 的外显子缺失。
PLoS One. 2022 Jul 1;17(7):e0270506. doi: 10.1371/journal.pone.0270506. eCollection 2022.
4
Identification of cerebrospinal fluid and serum metabolomic biomarkers in first episode psychosis patients.首发精神病患者脑脊液和血清代谢组学生物标志物的鉴定。
Transl Psychiatry. 2022 Jun 3;12(1):229. doi: 10.1038/s41398-022-02000-1.
5
Appraisal of patient-level health economic models of severe mental illness: systematic review.严重精神疾病患者层面健康经济模型评估：系统评价
Br J Psychiatry. 2021 Aug 19;220(2):1-12. doi: 10.1192/bjp.2021.121.
6
Artificial intelligence-based classification of schizophrenia: A high density electroencephalographic and support vector machine study.基于人工智能的精神分裂症分类：一项高密度脑电图与支持向量机研究。
Indian J Psychiatry. 2020 May-Jun;62(3):273-282. doi: 10.4103/psychiatry.IndianJPsychiatry_91_20. Epub 2020 May 15.
7
Advances in clinical staging, early intervention, and the prevention of psychosis.临床分期、早期干预及精神病预防方面的进展。
F1000Res. 2019 Nov 29;8. doi: 10.12688/f1000research.20346.1. eCollection 2019.
8
A crossroad for validating digital tools in schizophrenia and mental health.验证精神分裂症和心理健康领域数字工具的一个十字路口。
NPJ Schizophr. 2018 Apr 6;4(1):6. doi: 10.1038/s41537-018-0048-6.
本文引用的文献
1
Limits to Personalized Cancer Medicine.个性化癌症医学的局限性。
N Engl J Med. 2016 Sep 29;375(13):1289-94. doi: 10.1056/NEJMsb1607705.
2
Prediction of transition from ultra-high risk to first-episode psychosis using a probabilistic model combining history, clinical assessment and fatty-acid biomarkers.使用结合病史、临床评估和脂肪酸生物标志物的概率模型预测从超高风险到首发精神病的转变。
Transl Psychiatry. 2016 Sep 20;6(9):e897. doi: 10.1038/tp.2016.170.
3
Personalized Prediction of Psychosis: External Validation of the NAPLS-2 Psychosis Risk Calculator With the EDIPPP Project.精神病的个性化预测：利用EDIPPP项目对NAPLS-2精神病风险计算器进行外部验证
Am J Psychiatry. 2016 Oct 1;173(10):989-996. doi: 10.1176/appi.ajp.2016.15121565. Epub 2016 Jul 1.
4
Biomarker Tests for Molecularly Targeted Therapies--The Key to Unlocking Precision Medicine.分子靶向治疗的生物标志物检测——开启精准医学的关键
N Engl J Med. 2016 Jul 7;375(1):4-6. doi: 10.1056/NEJMp1604033. Epub 2016 Jun 1.
5
Pharmacogenetic Tests in Psychiatry: From Fear to Failure to Hype.精神病学中的药物遗传学检测：从恐惧到失败再到炒作
J Clin Psychopharmacol. 2016 Aug;36(4):299-304. doi: 10.1097/JCP.0000000000000522.
6
Convergence of Implementation Science, Precision Medicine, and the Learning Health Care System: A New Model for Biomedical Research.实施科学、精准医学与学习型医疗保健系统的融合：生物医学研究的新模式。
JAMA. 2016 May 10;315(18):1941-2. doi: 10.1001/jama.2016.3867.
7
Precision Medicine for Ischemic Stroke.缺血性中风的精准医学
JAMA Neurol. 2016 Jul 1;73(7):773-4. doi: 10.1001/jamaneurol.2016.0087.
8
Advances in the genetics of schizophrenia: toward a network and pathway view for drug discovery.精神分裂症遗传学研究进展：为药物研发建立网络和途径视图。
Ann N Y Acad Sci. 2016 Feb;1366(1):61-75. doi: 10.1111/nyas.13066.
9
Towards diagnostic markers for the psychoses.寻找精神病的诊断标志物。
Lancet Psychiatry. 2016 Apr;3(4):375-85. doi: 10.1016/S2215-0366(16)00021-3.
10
Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers.利用基于脑的生物标志物识别不同的精神病生物型
Am J Psychiatry. 2016 Apr 1;173(4):373-84. doi: 10.1176/appi.ajp.2015.14091200. Epub 2015 Dec 7.
Zotero 插件